A novel non-toxic preconditioning regimen for cancer cell therapy
Ended Project Grant Awarded Last action
- Award ID
- R43CA246896
- Recipient
-
AVM Biotechnology, Inc. UEI D29NFMS3DJJ8
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $224,770
Award facts
- Assistance listing
- 93.395 Cancer Treatment Research
- Completion date
- Originally
- Place of performance
- Washington, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $0 | |
| Original award | $224,770 |
Quick answers
Who received award R43CA246896?
R43CA246896 was awarded to AVM Biotechnology, Inc. by National Cancer Institute (National Institutes of Health) on July 1, 2020.
How much is award R43CA246896 worth?
$224,770 has been obligated on R43CA246896.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award